Abstract
Urothelial carcinoma of the bladder is one of the most common malignancies in the industrialized world, mainly caused by smoking and occupational exposure to chemicals. The favorable prognosis of early stage bladder cancer underscores the importance of early detection for the treatment of this disease. The high recurrence rate of this malignancy also highlights the need for close post-diagnosis monitoring of bladder cancer patients. As for other malignancies, aberrant DNA methylation has been shown to play a crucial role in the initiation and progression of bladder cancer, and thus holds great promise as a diagnostic and prognostic biological marker. Here, we describe a protocol for a versatile DNA methylation enrichment method, the Methylated CpG Island Recovery Assay (MIRA), which enables analysis of the DNA methylation status in individual genes or across the entire genome. MIRA is based on the ability of the methyl-binding domain (MBD) proteins, the MBD2B/MBD3L1 complex, to specifically bind methylated CpG dinucleotides. This easy-to-perform method can be used to analyze the methylome of bladder cancer or urothelial cells shed in the urine to elucidate the evolution of bladder carcinogenesis and/or identify epigenetic signatures of chemicals known to cause this malignancy.
Key words
This is a preview of subscription content, log in via an institution.
References
Stewart BW, Wild CP (eds) (2014) World Cancer Report 2014. International Agency for Research on Cancer (IARC), Lyon, France
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2016) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108. doi:10.1016/j.eururo.2016.06.010
Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, Guo CC, Lotan Y, Kassouf W (2016) Bladder cancer. Lancet 388(10061):2796–2810. doi:10.1016/S0140-6736(16)30512-8
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30
Carradori S, Cristini C, Secci D, Gulia C, Gentile V, Di Pierro GB (2012) Current and emerging strategies in bladder cancer. Anticancer Agents Med Chem 12(6):589–603
Besaratinia A, Cockburn M, Tommasi S (2013) Alterations of DNA methylome in human bladder cancer. Epigenetics 8(10):1013–1022
Griffiths TR, on behalf of Action on Bladder Cancer (2013) Current perspectives in bladder cancer management. Int J Clin Pract 67(5):435–448
Miremami J, Kyprianou N (2014) The promise of novel molecular markers in bladder cancer. Int J Mol Sci 15(12):23897–23908
Netto GJ (2012) Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 9(1):41–51
Boffetta P (2008) Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol Suppl 218:45–54
Besaratinia A, Tommasi S (2013) Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions. FASEB J 27(6):2090–2100
Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND (2012) Bladder cancer risk from occupational and environmental exposures. Urol Oncol 30(2):199–211
U.S. Department of Health and Human Services (2014) The health consequences of smoking – 50 years of progress. A report of the Surgeon General. U.S. Department of Health and Human Services. Public Health Service. Office of the Surgeon General. Rockville, MD
Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7):737–745
Internationa Agency for Research on Cancer (IARC) (2010) Some aromatic amines, organic dyes, and related exposures. In: IARC monographs on the evaluation of carcinogenic risk to humans, vol 99. Lyon, France
Scelo G, Brennan P (2007) The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol 4(4):205–217
Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, Silverman D, Malats N, Chanock S, Wu X, Karagas MR, Andrew AS, Nelson HH, Bishop DT, Sak SC, Choudhury A, Barrett JH, Elliot F, Corral R, Joshi AD, Gago-Dominguez M, Cortessis VK, Xiang YB, Gao YT, Vineis P, Sacerdote C, Guarrera S, Polidoro S, Allione A, Gurzau E, Koppova K, Kumar R, Rudnai P, Porru S, Carta A, Campagna M, Arici C, Park SS, Garcia-Closas M, International Consortium of Bladder C (2009) Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 69(17):6857–6864
Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8(4):253–262
Cortessis VK, Thomas DC, Levine AJ, Breton CV, Mack TM, Siegmund KD, Haile RW, Laird PW (2012) Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet 131(10):1565–1589
Schulz WA, Goering W (2016) DNA methylation in urothelial carcinoma. Epigenomics 8(10):1415–1428. doi:10.2217/epi-2016-0064
Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22(1):50–55
You JS, Jones PA (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22(1):9–20
Feinberg AP, Koldobskiy MA, Gondor A (2016) Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet 17(5):284–299
Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9(6):465–476
Kulis M, Esteller M (2010) DNA methylation and cancer. Adv Genet 70:27–56
Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7):484–492
Besaratinia A, Tommasi S (2014) Epigenetics of human melanoma: promises and challenges. J Mol Cell Biol 6(5):356–367
Beekman R, Kulis M, Martín-Subero JI (2016) The DNA methylomes of cancer. In: Fraga M, Fernandez AF (eds) Epigenomics in health and disease Elsevier Inc, pp 183–207
Verma M (2015) The role of Epigenomics in the study of cancer biomarkers and in the development of diagnostic tools. Adv Exp Med Biol 867:59–80
Rodriguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17(3):330–339
Costa-Pinheiro P, Montezuma D, Henrique R, Jeronimo C (2015) Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics 7(6):1003–1015
Chihara Y, Kanai Y, Fujimoto H, Sugano K, Kawashima K, Liang G, Jones PA, Fujimoto K, Kuniyasu H, Hirao Y (2013) Diagnostic markers of urothelial cancer based on DNA methylation analysis. BMC Cancer 13:275
Harb-de la Rosa A, Acker M, Kumar RA, Manoharan M (2015) Epigenetics application in the diagnosis and treatment of bladder cancer. Can J Urol 22(5):7947–7951
Wu P, Cao Z, Wu S (2016) New progress of epigenetic biomarkers in urological cancer. Dis Markers 2016:9864047. doi:10.1155/2016/9864047
Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP (2011) Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev 20(7):1483–1491
Sapre N, Anderson PD, Costello AJ, Hovens CM, Corcoran NM (2014) Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise? Urol Oncol 32(1):48.e49–48.e17
Laird PW (2010) Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 11(3):191–203
Fouse SD, Nagarajan RO, Costello JF (2010) Genome-scale DNA methylation analysis. Epigenomics 2(1):105–117
Taylor KH, Shi H, Caldwell CW (2010) Next generation sequencing: advances in characterizing the methylome. Genes 1(2):143–165
Olkhov-Mitsel E, Bapat B (2012) Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med 1(2):237–260
Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP (2009) Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 11(1):R14
Mitchell N, Deangelis JT, Tollefsbol TO (2011) Methylated-CpG Island recovery assay. Methods Mol Biol 791:125–133
Choi JH, Li Y, Guo J, Pei L, Rauch TA, Kramer RS, Macmil SL, Wiley GB, Bennett LB, Schnabel JL, Taylor KH, Kim S, Xu D, Sreekumar A, Pfeifer GP, Roe BA, Caldwell CW, Bhalla KN, Shi H (2010) Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencing. PLoS One 5(9):e13020
Almamun M, Levinson BT, Gater ST, Schnabel RD, Arthur GL, Davis JW, Taylor KH (2014) Genome-wide DNA methylation analysis in precursor B-cells. Epigenetics 9(12):1588–1595
Green BB, McKay SD, Kerr DE (2015) Age dependent changes in the LPS induced transcriptome of bovine dermal fibroblasts occurs without major changes in the methylome. BMC Genomics 16:30
Tommasi S, Kim SI, Zhong X, Wu X, Pfeifer GP, Besaratinia A (2010) Investigating the epigenetic effects of a prototype smoke-derived carcinogen in human cells. PLoS One 5(5):e10594
Tommasi S, Zheng A, Weninger A, Bates SE, Li XA, Wu X, Hollstein M, Besaratinia A (2013) Mammalian cells acquire epigenetic hallmarks of human cancer during immortalization. Nucleic Acids Res 41(1):182–195
Tommasi S, Zheng A, Yoon JI, Li AX, Wu X, Besaratinia A (2012) Whole DNA methylome profiling in mice exposed to secondhand smoke. Epigenetics 7(11):1302–1314
Tommasi S, Zheng A, Yoon JI, Besaratinia A (2014) Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis. Carcinogenesis 35(8):1726–1736
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Acknowledgments
ST and AB declare no conflicts of interest.
Work of the authors is funded by grants from the National Institute of Dental and Craniofacial Research of the National Institutes of Health (1R01DE026043-01) to AB and from the University of California Tobacco-Related Disease Research Program (TRDRP-25IP-0001) to ST.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Tommasi, S., Besaratinia, A. (2018). A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer. In: Schulz, W., Hoffmann, M., Niegisch, G. (eds) Urothelial Carcinoma. Methods in Molecular Biology, vol 1655. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7234-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7234-0_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7233-3
Online ISBN: 978-1-4939-7234-0
eBook Packages: Springer Protocols